Sociedad Americana de Hirudoterapia

Direction de la santé — Division de la Pharmacie et des Médicaments, Luxembourg

Luxembourg DPM · Luxembourg · europe

Regulatory jurisdiction profileJurisdictional reference
Unregulatednational regulator

Luxembourg's Direction de la santé (Division of Pharmacy and Medicines) — leeches fall under EU medical-device frameworks (MDR 2017/745) as implemented through Luxembourgish national law; leech-specific national authorisation has not been independently verified by ASH.

Regulatory Profile

Agency type
national regulator
Region
europe
Country
Luxembourg
Leech status
unregulated
Last ASH review
2026-05-27

Relevant Regulation Codes

  • Luxembourg Law of 25 November 1982 on Medicinal Products, as amended
  • EU Medical Device Regulation (MDR) 2017/745 — as transposed into Luxembourgish law
  • Luxembourg Grand-Ducal Regulations on Medical Devices

Prescriber Requirements

  • Luxembourg-licensed physician (under the Ministry of Health) — order required for any biomedical device application
  • Allied health professional application under physician supervision per institutional protocol

Supply Chain & GMP

Division de la Pharmacie registration as applicable; French and German-language labelling (with Luxembourgish supplementary information as relevant). Standard cold-chain conditions; EU intra-community movement under MDR applies.

Import/Export Rules

Free movement within the EU single market under MDR; Veterinary and Food Administration (ALVA) clearance for live invertebrates from non-EU origin; CITES Appendix II paperwork for Hirudo medicinalis / verbana on extra-EU import.

Reimbursement Context

Caisse Nationale de Santé (CNS) coverage depends on inpatient bundling; outpatient hirudotherapy is generally not separately reimbursed.

ASH Editorial Notes

Leech-specific pathway not independently verified by ASH; falls under general EU MDR framework as transposed into Luxembourgish law. Luxembourg's regulatory practice is often closely harmonised with the Benelux partners (Netherlands MEB, Belgian FAMHP); whether this includes specific guidance on live-organism medical devices has not been independently mapped by ASH.

Related Jurisdictions

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.